PAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from The American Business Awards

02 June, 2016

BOSTON, June 2, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business AwardsSM. The judges awarded PAREXEL a Gold Stevie® Award and recognized the Company’s investments in innovation and expanded capabilities across the drug development continuum in 2015 as specifics for the accolade.

Related News
PAREXEL Announces Agreement to Acquire Quantum Solutions India
PAREXEL International Corporation announced today that the Company has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India (“QSI”), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India. Read Full Release
PAREXEL International Reports Fourth Quarter And Fiscal Year 2013 Results
PAREXEL International Corp. (NASDAQ: PRXL) reported financial results for the fourth quarter and Fiscal Year 2013. For the three months ended June 30, 2013 consolidated service revenue increased by 18% to $463.1 million compared with $392.6 million in the prior year period. Read Full Release